Molecular mechanisms of cisplatin resistance in cervical cancer

References

• TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
   PubMed Web of Science ®Google Scholar
• Diaz-PadillaIMonkBJMackayHJOakninATreatment of metastatic cervical cancer: future directions involving targeted agentsCrit Rev Oncol Hematol201385330331422883215
   PubMed Web of Science ®Google Scholar
• LorussoDPetrelliFCoinuARaspagliesiFBarniSA systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancerGynecol Oncol2014133111712324486604
   PubMed Web of Science ®Google Scholar
• ShenDWPouliotLMHallMDGottesmanMMCisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changesPharmacol Rev201264370672122659329
   PubMed Web of Science ®Google Scholar
• SeolHJUlakRKiKDLeeJMCytotoxic and targeted systemic therapy in advanced and recurrent cervical cancer: experience from clinical trialsTohoku J Exp Med2014232426927624695215
   PubMed Web of Science ®Google Scholar
• ChaoCCDecreased accumulation as a mechanism of resistance to cis-diamminedichloroplatinum(II) in cervix carcinoma HeLa cells: relation to DNA repairMol Pharmacol1994456113711448022407
   PubMed Web of Science ®Google Scholar
• BerettaGLGattiLTinelliSCellular pharmacology of cisplatin in relation to the expression of human copper transporter CTR1 in different pairs of cisplatin-sensitive and -resistant cellsBiochem Pharmacol200468228329115194000
   PubMed Web of Science ®Google Scholar
• LanziCPeregoPSupinoRDecreased drug accumulation and increased tolerance to DNA damage in tumor cells with a low level of cisplatin resistanceBiochem Pharmacol1998558124712549719480
   PubMed Web of Science ®Google Scholar
• CiarimboliGMembrane transporters as mediators of cisplatin effects and side effectsScientifica (Cairo)2012201247382924278698
   PubMedGoogle Scholar
• GalluzziLVitaleIMichelsJSystems biology of cisplatin resistance: past, present and futureCell Death Dis20145e125724874729
   PubMed Web of Science ®Google Scholar
• ZisowskyJKoegelSLeyersSRelevance of drug uptake and efflux for cisplatin sensitivity of tumor cellsBiochem Pharmacol200773229830717097621
   PubMed Web of Science ®Google Scholar
• DuXWangXLiHSunHComparison between copper and cisplatin transport mediated by human copper transporter 1 (hCTR1)Metallomics20124767968522552365
   PubMed Web of Science ®Google Scholar
• IshidaSMcCormickFSmith-McCuneKHanahanDEnhancing tumor-specific uptake of the anticancer drug cisplatin with a copper chelatorCancer Cell201017657458320541702
   PubMed Web of Science ®Google Scholar
• BorstPEversRKoolMWijnholdsJA family of drug transporters: the multidrug resistance-associated proteinsJ Natl Cancer Inst200092161295130210944550
   PubMed Web of Science ®Google Scholar
• GalluzziLSenovillaLVitaleIMolecular mechanisms of cisplatin resistanceOncogene201231151869188321892204
   PubMed Web of Science ®Google Scholar
• RoyMMukherjeeSReversal of resistance towards cisplatin by curcumin in cervical cancer cellsAsian Pac J Cancer Prev20141531403141024606473
   PubMedGoogle Scholar
• CuiYKonigJBuchholzJKSpringHLeierIKepplerDDrug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cellsMol Pharmacol199955592993710220572
   PubMed Web of Science ®Google Scholar
• KoikeKKawabeTTanakaTA canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cellsCancer Res19975724547554799407953
   PubMed Web of Science ®Google Scholar
• LiedertBMaternaVSchadendorfDThomaleJLageHOverexpression of cMOAT (MRP2/ABCC2) is associated with decreased formation of platinum-DNA adducts and decreased G2-arrest in melanoma cells resistant to cisplatinJ Invest Dermatol2003121117217612839578
   PubMed Web of Science ®Google Scholar
• LiQPengXYangHRodriguezJAShuYContribution of organic cation transporter 3 to cisplatin cytotoxicity in human cervical cancer cellsJ Pharm Sci2012101139440421905038
   PubMed Web of Science ®Google Scholar
• DohertyBLawlorDGilletJPGottesmanMO’LearyJJStordalBCollateral sensitivity to cisplatin in KB-8-5-11 drug-resistant cancer cellsAnticancer Res201434150350724403508
   PubMedGoogle Scholar
• SakaedaTNakamuraTHiraiMMDR1 up-regulated by apoptotic stimuli suppresses apoptotic signalingPharm Res20021991323132912403069
   PubMed Web of Science ®Google Scholar
• TakaraKObataYYoshikawaEMolecular changes to HeLa cells on continuous exposure to cisplatin or paclitaxelCancer Chemother Pharmacol200658678579316534613
   PubMed Web of Science ®Google Scholar
• OkadaTMurataKHiroseRUpregulated expression of FGF13/FHF2 mediates resistance to platinum drugs in cervical cancer cellsSci Rep20133289924113164
   PubMed Web of Science ®Google Scholar
• MengFTanSLiuTSongHLouGPredictive significance of combined LAPTM4B and VEGF expression in patients with cervical cancerTumour Biol Epub2015112
   Google Scholar
• LiLWeiXHPanYPLAPTM4B: a novel cancer-associated gene motivates multidrug resistance through efflux and activating PI3K/AKT signalingOncogene201029435785579520711237
   PubMed Web of Science ®Google Scholar
• MellishKJKellandLRHarrapKRIn vitro platinum drug chemo-sensitivity of human cervical squamous cell carcinoma cell lines with intrinsic and acquired resistance to cisplatinBr J Cancer19936822402508347478
   PubMed Web of Science ®Google Scholar
• NishikawaKRosenblumMGNewmanRAPanditaTKHittelmanWNDonatoNJResistance of human cervical carcinoma cells to tumor necrosis factor correlates with their increased sensitivity to cisplatin: evidence of a role for DNA repair and epidermal growth factor receptorCancer Res19925217475847651380890
   PubMed Web of Science ®Google Scholar
• KonishiINanbuKMandaiMTumor response to neoadjuvant chemotherapy correlates with the expression of P-glycoprotein and PCNA but not GST-pi in the tumor cells of cervical carcinomaGynecol Oncol19987033653719790789
   PubMed Web of Science ®Google Scholar
• ChaoCCHuangYTMaCMChouWYLin-ChaoSOverexpression of glutathione S-transferase and elevation of thiol pools in a multidrug-resistant human colon cancer cell lineMol Pharmacol199241169751346333
   PubMed Web of Science ®Google Scholar
• ZhangYShenXHeat shock protein 27 protects L929 cells from cisplatin-induced apoptosis by enhancing Akt activation and abating suppression of thioredoxin reductase activityClin Cancer Res200713102855286417504983
   PubMed Web of Science ®Google Scholar
• ChaoCCEnhanced excision repair of DNA damage due to cis-diamminedichloroplatinum(II) in resistant cervix carcinoma HeLa cellsEur J Pharmacol199426833473557805758
   PubMed Web of Science ®Google Scholar
• DasariSTchounwouPBCisplatin in cancer therapy: molecular mechanisms of actionEur J Pharmacol201474036437825058905
   PubMed Web of Science ®Google Scholar
• MartinLPHamiltonTCSchilderRJPlatinum resistance: the role of DNA repair pathwaysClin Cancer Res20081451291129518316546
   PubMed Web of Science ®Google Scholar
• ToriiYKatoRMinamiYHasegawaKFujiiTUdagawaYERCC1 expression and chemosensitivity in uterine cervical adenocarcinoma cellsAnticancer Res201434110711524403450
   PubMedGoogle Scholar
• BaiZLWangYYZheHHeJLHaiPERCC1 mRNA levels can predict the response to cisplatin-based concurrent chemoradiotherapy of locally advanced cervical squamous cell carcinomaRadiat Oncol2012722123259415
   PubMed Web of Science ®Google Scholar
• ParkJSJeonEKChunSHERCC1 (excision repair cross-complementation group 1) expression as a predictor for response of neoadjuvant chemotherapy for FIGO stage 2B uterine cervix cancerGynecol Oncol2011120227527921093896
   PubMed Web of Science ®Google Scholar
• HasegawaKKatoRToriiYIchikawaROeSUdagawaYThe relationship between ERCC1 expression and clinical outcome in patients with FIGO stage I to stage II uterine cervical adenocarcinomaInt J Gynecol Cancer20112181479148521720251
   PubMed Web of Science ®Google Scholar
• MartelliLRagazziEDi MarioFBasatoMMartelliMCisplatin and oxaliplatin cytotoxic effects in sensitive and cisplatin-resistant human cervical tumor cells: time and mode of application dependencyAnticancer Res200929103931393719846931
   PubMed Web of Science ®Google Scholar
• ZhangYShuYMWangSFDaBHWangZHLiHBStabilization of mismatch repair gene PMS2 by glycogen synthase kinase 3beta is implicated in the treatment of cervical carcinomaBMC Cancer2010105820178594
   PubMed Web of Science ®Google Scholar
• YangLShiTLiuFREV3L, a promising target in regulating the chemosensitivity of cervical cancer cellsPLoS One2015103e012033425781640
   PubMed Web of Science ®Google Scholar
• BrozovicAFritzGChristmannMLong-term activation of SAPK/JNK, p38 kinase and fas-L expression by cisplatin is attenuated in human carcinoma cells that acquired drug resistanceInt J Cancer2004112697498515386344
   PubMed Web of Science ®Google Scholar
• VenkatramanMAntoRJNairAVargheseMKarunagaranDBiological and chemical inhibitors of NF-kappaB sensitize SiHa cells to cisplatin-induced apoptosisMol Carcinog2005441515916044419
   PubMed Web of Science ®Google Scholar
• SiddikZHCisplatin: mode of cytotoxic action and molecular basis of resistanceOncogene200322477265727914576837
   PubMed Web of Science ®Google Scholar
• DingZYangXPaterATangSCResistance to apoptosis is correlated with the reduced caspase-3 activation and enhanced expression of antiapoptotic proteins in human cervical multidrug-resistant cellsBiochem Biophys Res Commun2000270241542010753639
   PubMed Web of Science ®Google Scholar
• BrozovicAOsmakMActivation of mitogen-activated protein kinases by cisplatin and their role in cisplatin-resistanceCancer Lett2007251111617125914
   PubMed Web of Science ®Google Scholar
• ChenJXiongJLiuHChernenkoGTangSCDistinct BAG-1 isoforms have different anti-apoptotic functions in BAG-1-transfected C33A human cervical carcinoma cell lineOncogene200221467050705912370827
   PubMed Web of Science ®Google Scholar
• Henriquez-HernandezLALloretMPinarBBCL-2, in combination with MVP and IGF-1R expression, improves prediction of clinical outcome in complete response cervical carcinoma patients treated by radiochemotherapyGynecol Oncol2011122358558921708403
   PubMed Web of Science ®Google Scholar
• OzfilizPArisanEDCoker-GurkanABag-1L is a stress-withstand molecule prevents the downregulation of Mcl-1 and c-Raf under control of heat shock proteins in cisplatin treated HeLa cervix cancer cellsAsian Pac J Cancer Prev201415114475448224969872
   PubMedGoogle Scholar
• DeanMFojoTBatesSTumour stem cells and drug resistanceNat Rev Cancer20055427528415803154
   PubMed Web of Science ®Google Scholar
• WangXMartindaleJLHolbrookNJRequirement for ERK activation in cisplatin-induced apoptosisJ Biol Chem200027550394353944310993883
   PubMed Web of Science ®Google Scholar
• BasuATuHActivation of ERK during DNA damage-induced apoptosis involves protein kinase CdeltaBiochem Biophys Res Commun200533441068107316039614
   PubMed Web of Science ®Google Scholar
• YehPYChuangSEYehKHSongYCEaCKChengALIncrease of the resistance of human cervical carcinoma cells to cisplatin by inhibition of the MEK to ERK signaling pathway partly via enhancement of anticancer drug-induced NF kappa B activationBiochem Pharmacol20026381423143011996883
   PubMed Web of Science ®Google Scholar
• SultanaHKigawaJKanamoriYChemosensitivity and p53-Bax pathway-mediated apoptosis in patients with uterine cervical cancerAnn Oncol200314221421912562647
   PubMed Web of Science ®Google Scholar
• GarzettiGGCiavattiniAProvincialiMExpression of p53 and apoptosis of tumor cells in locally advanced cervical carcinoma after cisplatin based neoadjuvant chemotherapyAnticancer Res1996165B322932348920796
   PubMed Web of Science ®Google Scholar
• GarzettiGGCiavattiniALucariniGModulation of expression of p53 and cell proliferation in locally advanced cervical carcinoma after neoadjuvant combination chemotherapyEur J Obstet Gynecol Reprod Biol199563131368674562
   PubMed Web of Science ®Google Scholar
• SaitoTTakeharaMTanakaRCorrelation between responsiveness of neoadjuvant chemotherapy and apoptosis-associated proteins for cervical adenocarcinomaGynecol Oncol200492128429214751172
   PubMed Web of Science ®Google Scholar
• KarinMNuclear factor-kappaB in cancer development and progressionNature2006441709243143616724054
   PubMed Web of Science ®Google Scholar
• ZhengXLvJShenQSynergistic effect of pyrrolidine dithiocarbamate and cisplatin in human cervical carcinomaReprod Sci201421101319132524594834
   PubMed Web of Science ®Google Scholar
• ShiTYChengXYuKDFunctional variants in TNFAIP8 associated with cervical cancer susceptibility and clinical outcomesCarcinogenesis201334477077823299407
   PubMed Web of Science ®Google Scholar
• ZhuKChenLHanXWangJWangJShort hairpin RNA targeting Twist1 suppresses cell proliferation and improves chemosensitivity to cisplatin in HeLa human cervical cancer cellsOncol Rep20122741027103422245869
   PubMed Web of Science ®Google Scholar
• YooBKEmdadLLeeSGAstrocyte elevated gene-1 (AEG-1): a multifunctional regulator of normal and abnormal physiologyPharmacol Ther201113011821256156
   PubMed Web of Science ®Google Scholar
• LiuXWangDLiuHKnockdown of astrocyte elevated gene-1 (AEG-1) in cervical cancer cells decreases their invasiveness, epithelial to mesenchymal transition, and chemoresistanceCell Cycle201413111702170724675891
   PubMed Web of Science ®Google Scholar
• DraytonRMThe role of microRNA in the response to cisplatin treatmentBiochem Soc Trans201240482182522817741
   PubMedGoogle Scholar
• PouliotLMShenDWSuzukiTHallMDGottesmanMMContributions of microRNA dysregulation to cisplatin resistance in adenocarcinoma cellsExp Cell Res2013319456657423137650
   PubMed Web of Science ®Google Scholar
• ChenYKeGHanDLiangSYangGWuXMicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCDExp Cell Res20143201122024183997
   PubMed Web of Science ®Google Scholar
• LeiCWangYHuangYUp-regulated miR155 reverses the epithelial-mesenchymal transition induced by EGF and increases chemo-sensitivity to cisplatin in human Caski cervical cancer cellsPLoS One2012712e5231023284982
   PubMed Web of Science ®Google Scholar
• WangFLiuMLiXTangHMiR-214 reduces cell survival and enhances cisplatin-induced cytotoxicity via down-regulation of Bcl2l2 in cervical cancer cellsFEBS Lett2013587548849523337879
   PubMed Web of Science ®Google Scholar
• ZhangGSunLLuXCisplatin treatment leads to changes in nuclear protein and microRNA expressionMutat Res20127461667722475935
   PubMed Web of Science ®Google Scholar
• LiuSYZhengPSHigh aldehyde dehydrogenase activity identifies cancer stem cells in human cervical cancerOncotarget20134122462247524318570
   PubMed Web of Science ®Google Scholar
• CasagrandeNDe PaoliMCelegatoMPreclinical evaluation of a new liposomal formulation of cisplatin, lipoplatin, to treat cisplatin-resistant cervical cancerGynecol Oncol2013131374475224029417
   PubMed Web of Science ®Google Scholar
• WangLGuoHLinCYangLWangXEnrichment and characterization of cancer stem-like cells from a cervical cancer cell lineMol Med Rep2014962117212324676900
   PubMed Web of Science ®Google Scholar
• BaiTTanakaTYukawaKUmesakiNA novel mechanism for acquired cisplatin-resistance: suppressed translation of death-associated protein kinase mRNA is insensitive to 5-aza-2′-deoxycitidine and trichostatin in cisplatin-resistant cervical squamous cancer cellsInt J Oncol200628249750816391806
   PubMed Web of Science ®Google Scholar
• LiuBChengYLiuQBaoJKYangJMAutophagic pathways as new targets for cancer drug developmentActa Pharmacol Sin20103191154116420694022
   PubMed Web of Science ®Google Scholar
• XuYYuHQinHInhibition of autophagy enhances cisplatin cytotoxicity through endoplasmic reticulum stress in human cervical cancer cellsCancer Lett2012314223224322019047
   PubMed Web of Science ®Google Scholar
• SunYLiuJHJinLOver-expression of the Beclin1 gene upregulates chemosensitivity to anti-cancer drugs by enhancing therapy-induced apoptosis in cervix squamous carcinoma CaSki cellsCancer Lett2010294220421020207475
   PubMed Web of Science ®Google Scholar
• XuYWangNDingYAmmonium chloride enhances cisplatin cytotoxicity through DNA double-strand breaks in human cervical cancer cellsOncol Rep20133031195120023783842
   PubMed Web of Science ®Google Scholar
• LeischingGRLoosBBothaMHEngelbrechtAMThe role of mTOR during cisplatin treatment in an in vitro and ex vivo model of cervical cancerToxicology2015335727826201060
   PubMed Web of Science ®Google Scholar
• ShenDWAkiyamaSSchoenleinPPastanIGottesmanMMCharacterisation of high-level cisplatin-resistant cell lines established from a human hepatoma cell line and human KB adenocarcinoma cells: cross-resistance and protein changesBr J Cancer19957146766837710928
   PubMed Web of Science ®Google Scholar
• CastagnaAAntonioliPAstnerHA proteomic approach to cisplatin resistance in the cervix squamous cell carcinoma cell line A431Proteomics20044103246326715378690
   PubMed Web of Science ®Google Scholar
• GallerneCProlaALemaireCHsp90 inhibition by PU-H71 induces apoptosis through endoplasmic reticulum stress and mitochondrial pathway in cancer cells and overcomes the resistance conferred by Bcl-2Biochim Biophys Acta2013183361356136623485394
   PubMed Web of Science ®Google Scholar
• JinLShenQDingSJiangWJiangLZhuXImmunohistochemical expression of annexin A2 and S100A proteins in patients with bulky stage IB-IIA cervical cancer treated with neoadjuvant chemotherapyGynecol Oncol2012126114014622487537
   PubMed Web of Science ®Google Scholar
• ZouSShenQHuaYJiangWZhangWZhuXProteomic identification of neoadjuvant chemotherapy-related proteins in bulky stage IB-IIA squamous cervical cancerReprod Sci201320111356136423599374
   PubMed Web of Science ®Google Scholar
• ChavezJDHoopmannMRWeisbrodCRTakaraKBruceJEQuantitative proteomic and interaction network analysis of cisplatin resistance in HeLa cellsPLoS One201165e1989221637840
   PubMed Web of Science ®Google Scholar
• WuZZLuHPChaoCCIdentification and functional analysis of genes which confer resistance to cisplatin in tumor cellsBiochem Pharmacol201080226227620361941
   PubMed Web of Science ®Google Scholar
• VoglSESeltzerVCamachoFCalanogADianhydrogalactitol and cisplatin in combination for advanced cancer of the uterine cervixCancer Treat Rep19826610180918126889913
   PubMedGoogle Scholar
• MistryPKellandLRAbelGSidharSHarrapKRThe relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell linesBr J Cancer19916422152201892748
   PubMed Web of Science ®Google Scholar
• KoberleBMastersJRHartleyJAWoodRDDefective repair of cisplatin-induced DNA damage caused by reduced XPA protein in testicular germ cell tumoursCurr Biol19999527327610074455
   PubMed Web of Science ®Google Scholar
• IshidaSLeeJThieleDJHerskowitzIUptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammalsProc Natl Acad Sci USA20029922142981430212370430
   PubMed Web of Science ®Google Scholar
• MartelliLDi MarioFRagazziEDifferent accumulation of cisplatin, oxaliplatin and JM216 in sensitive and cisplatin-resistant human cervical tumour cellsBiochem Pharmacol200672669370016844093
   PubMed Web of Science ®Google Scholar
• KuoDYBlankSVChristosPJPaclitaxel plus oxaliplatin for recurrent or metastatic cervical cancer: a New York Cancer Consortium StudyGynecol Oncol2010116344244619931137
   PubMed Web of Science ®Google Scholar
• TewariKSSillMWLongHJ3rdImproved survival with bevacizumab in advanced cervical cancerN Engl J Med2014370873474324552320
   PubMed Web of Science ®Google Scholar
• SahinKTuzcuMBasakNSensitization of cervical cancer cells to cisplatin by genistein: the role of NFkappaB and Akt/mTOR signaling pathwaysJ Oncol2012201246156223056046
   PubMedGoogle Scholar
• SinghMBhuiKSinghRShuklaYTea polyphenols enhance cisplatin chemosensitivity in cervical cancer cells via induction of apoptosisLife Sci201393171623399702
   PubMed Web of Science ®Google Scholar
• ParienteRParienteJARodriguezABEspinoJMelatonin sensitizes human cervical cancer HeLa cells to cisplatin-induced cytotoxicity and apoptosis: effects on oxidative stress and DNA fragmentationJ Pineal Res2016601556426462739
   PubMed Web of Science ®Google Scholar
• Segovia-MendozaMJuradoRMirRMedinaLAPrado-GarciaHGarcia-LopezPAntihormonal agents as a strategy to improve the effect of chemo-radiation in cervical cancer: in vitro and in vivo studyBMC Cancer2015152125622528
   PubMed Web of Science ®Google Scholar
• JuradoRLopez-FloresAAlvarezAGarcia-LopezPCisplatin cytotoxicity is increased by mifepristone in cervical carcinoma: an in vitro and in vivo studyOncol Rep20092251237124519787245
   PubMed Web of Science ®Google Scholar
• LiCYeHMifepristone sensitizing cisplatin for cervical adenocarcinoma HeLa cell sensitivity to chemotherapy and its mechanismEur J Gynaecol Oncol201334214214723781585
   PubMed Web of Science ®Google Scholar
• YokoyamaMNoguchiMNakaoYPaterAIwasakaTThe tea polyphenol, (−)-epigallocatechin gallate effects on growth, apoptosis, and telomerase activity in cervical cell linesGynecol Oncol200492119720414751158
   PubMed Web of Science ®Google Scholar
• KilicUSahinKTuzcuMEnhancement of cisplatin sensitivity in human cervical cancer: epigallocatechin-3-gallateFront Nutr201512825988128
   PubMedGoogle Scholar
• LiYXingDChenQChenWREnhancement of chemotherapeutic agent-induced apoptosis by inhibition of NF-kappaB using ursolic acidInt J Cancer2010127246247319908232
   PubMed Web of Science ®Google Scholar
• GuptaRKSinghNMorinda citrifolia (Noni) alters oxidative stress marker and antioxidant activity in cervical cancer cell linesAsian Pac J Cancer Prev20131484603460624083710
   PubMedGoogle Scholar
• GuptaRKBanerjeeAPathakSSharmaCSinghNInduction of mitochondrial-mediated apoptosis by Morinda citrifolia (Noni) in human cervical cancer cellsAsian Pac J Cancer Prev201314123724223534730
   PubMedGoogle Scholar
• HeFWangQZhengXLWogonin potentiates cisplatin-induced cancer cell apoptosis through accumulation of intracellular reactive oxygen speciesOncol Rep201228260160522665077
   PubMed Web of Science ®Google Scholar